Psoriatic arthritis has no single definitive test. Diagnosis relies on a combination of physical examination, blood work, imaging, and your medical history, particularly whether you have psoriasis or a family history of it. Because the symptoms overlap with rheumatoid arthritis, gout, and other inflammatory conditions, the process is largely about fitting together multiple pieces of evidence and ruling out other causes.
What Doctors Look for on Physical Exam
The physical exam is the starting point and often the most revealing step. Your doctor will check your joints for swelling, tenderness, and range of motion, but they’re also looking for a handful of signs that are strongly associated with psoriatic arthritis specifically.
Dactylitis is one of the most distinctive. This is when an entire finger or toe swells uniformly, sometimes called a “sausage digit.” It shows up in about 35 to 50% of people with psoriatic arthritis and is far less common in rheumatoid arthritis (roughly 5%). Enthesitis, or inflammation where tendons and ligaments attach to bone, is another hallmark. It most often affects the Achilles tendon and the bottom of the heel where the plantar fascia connects. About 35% of patients have it, and it’s uncommon in rheumatoid arthritis.
Nail changes are a major clue. Nails are affected in about 80% of people with psoriatic arthritis, compared to only 20% of people who have psoriasis alone. The changes include uniform pitting (tiny dents in the nail surface), lifting of the nail from the nail bed, thickening under the nail, small reddish-brown spots (sometimes called “oil drops”), and splinter-like lines. These nail findings can be especially helpful in separating psoriatic arthritis from rheumatoid arthritis, gout, and osteoarthritis.
Doctors also pay attention to the pattern of joint involvement. Psoriatic arthritis tends to be asymmetric, affecting joints on one side of the body more than the other, and it has a preference for the small joints at the tips of the fingers and toes. Five recognized patterns exist: asymmetric involvement of a few joints, symmetric involvement of many joints (which can look like rheumatoid arthritis), disease concentrated in the fingertip joints, spinal involvement, and a rare destructive form called arthritis mutilans.
Blood Tests: What They Show and What They Don’t
There is no blood test that confirms psoriatic arthritis. Instead, blood work helps rule out other conditions and measure inflammation levels.
The most important result is rheumatoid factor (RF). Roughly 91 to 95% of people with psoriatic arthritis test negative for RF, which is why the condition is classified as a “seronegative” arthritis. A negative RF result in someone with joint inflammation and psoriasis points strongly toward psoriatic arthritis rather than rheumatoid arthritis. About 80% of people with rheumatoid arthritis test positive for both RF and anti-CCP antibodies, so these markers are useful for telling the two apart. If anti-CCP antibody levels are above a certain threshold, rheumatoid arthritis becomes far more likely than psoriatic arthritis.
Inflammation markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are often elevated but not always. An elevated ESR shows up in about 40% of patients. These numbers help gauge how active the disease is, but they aren’t specific to psoriatic arthritis since many inflammatory conditions raise them.
Some doctors also test for HLA-B27, a genetic marker. It’s positive in about 34% of people with psoriatic arthritis who have spinal involvement, and in 56% of those whose disease is primarily in the spine. A positive result doesn’t diagnose the condition on its own, but it adds supporting evidence when spinal symptoms are present.
Imaging: X-Rays, MRI, and Ultrasound
Imaging can reveal damage and inflammation patterns that are characteristic of psoriatic arthritis and distinct from other types of arthritis.
Standard X-rays may show new bone growth near joints, which is a feature that sets psoriatic arthritis apart from rheumatoid arthritis. Rheumatoid arthritis erodes bone without building new bone; psoriatic arthritis does both. In advanced cases, X-rays can reveal pencil-in-cup deformities, where the end of one bone narrows to a point while the adjacent bone develops a cup-shaped depression around it. Joint fusion (ankylosis) and severe bone resorption are also visible on X-rays in later stages.
MRI picks up earlier and subtler changes. The combination of enthesitis, bone marrow swelling in multiple locations, inflammation of the tissue lining the bone surface (periostitis), and synovitis extending beyond the joint capsule is considered nearly diagnostic. MRI is particularly useful early in the disease when X-rays still look normal, since it can detect soft tissue inflammation and bone marrow changes months or years before structural damage becomes visible on plain film. The location of bone marrow swelling also helps: in psoriatic arthritis it tends to cluster near entheses, while in rheumatoid arthritis it appears near where the joint capsule attaches.
Ultrasound, especially with power Doppler, can detect enthesitis and increased blood flow at inflamed tendon and ligament attachment points. It’s useful for confirming suspected enthesitis or dactylitis during a clinic visit without the cost or wait time of an MRI.
The CASPAR Criteria
Rheumatologists use a formal classification system called the CASPAR criteria (Classification Criteria for Psoriatic Arthritis) to confirm the diagnosis. To qualify, you must first have inflammatory disease in your joints, spine, or entheses. Then you need at least 3 points from the following:
- Current psoriasis: 2 points
- Personal history of psoriasis: 1 point
- Family history of psoriasis: 1 point
- Psoriatic nail changes: 1 point
- Negative rheumatoid factor: 1 point
- Current or past dactylitis: 1 point
- X-ray evidence of new bone formation near joints: 1 point
Notice that having active psoriasis is weighted most heavily at 2 points. Someone with current psoriasis and a negative rheumatoid factor already reaches the 3-point threshold. But psoriasis isn’t required: a person with a family history, nail pitting, and dactylitis would also meet the criteria without ever having skin plaques themselves.
Screening for People With Psoriasis
Up to 30% of people with psoriasis eventually develop psoriatic arthritis, so screening matters. A simple five-question tool called the PEST (Psoriasis Epidemiology Screening Tool) is used in primary care and dermatology clinics. It asks whether you’ve had a swollen joint, been told you have arthritis, noticed pits or holes in your nails, experienced heel pain, or had a finger or toe swell up for no clear reason. Each “yes” scores 1 point, and a score of 3 or more out of 5 suggests a referral to a rheumatologist is warranted. Guidelines recommend that people with psoriasis complete this screening annually.
Separating It From Rheumatoid Arthritis
The most common diagnostic confusion is between psoriatic arthritis and rheumatoid arthritis, since both cause joint pain, swelling, and stiffness. Several features help tell them apart. Psoriatic arthritis tends to involve joints asymmetrically, favors the fingertip joints, and commonly causes dactylitis, enthesitis, nail changes, and spinal involvement. Rheumatoid arthritis is usually symmetric, rarely involves the fingertip joints, and causes bone erosion without the new bone formation seen in psoriatic arthritis.
Serologically, the distinction is clearer. Mean RF levels in rheumatoid arthritis run about five times higher than in psoriatic arthritis (56 vs. 11 U/mL in one comparative study), and anti-CCP antibody levels are roughly seven times higher (14 vs. 2 U/mL). On imaging, cortical irregularity from new bone forming along the bone surface points toward psoriatic arthritis, while pure bone erosion without proliferation favors rheumatoid arthritis.
What Happens After Diagnosis
Once psoriatic arthritis is confirmed, the goal outlined in current EULAR guidelines (updated in 2023) is remission, or at minimum low disease activity, with regular reassessment and treatment adjustments as needed. Initial treatment for people with multiple affected joints or poor prognostic indicators like structural damage, elevated inflammation markers, dactylitis, or nail involvement typically starts with conventional disease-modifying drugs. If those aren’t enough, biologic therapies or targeted oral medications are the next steps. The specific choice depends on which parts of your body are most affected: skin-dominant disease, spinal involvement, eye inflammation, and bowel disease each steer the decision toward different drug classes.
Early diagnosis matters because joint damage in psoriatic arthritis can be irreversible. The disease can progress quietly, especially in people who attribute their joint symptoms to overuse or aging. If you have psoriasis and are developing new joint pain, stiffness that’s worse in the morning, or any of the hallmark signs like swollen digits or heel pain, a rheumatology evaluation can catch the disease before significant damage occurs.